Cancer Network: Can you tell us what CAR T - cell therapy is in general and then describe axicabtagene ciloleucel specifically? (cancernetwork.com)
Axicabtagene ciloleucel, also called axi - cel, is an autologous gene - and - cell therapy product. (cancernetwork.com)
Kite Pharma today reported positive 6 - month data from its pivotal ZUMA - 1 trial for its lead chimeric antigen receptor (CAR) T - cell candidate axicabtagene ciloleucel (formerly KTE - C19) in patients with chemorefractory aggressive B - cell non-Hodgkin lymphoma (NHL). (genengnews.com)